Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
DIASENSE is creating a Quantum Diamond Magnetic Microscope that will be able to detect magnetic fields at high rates.
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.
Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease.
Aida uses machine learning and gene expression of individual tumors to help clinicians to prescribe the best drugs for each cancer patient.
Incipiam Pharma focuses on developing innovative treatments for metabolic diseases by targeting energy expenditure.
Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
Akasi Pharma focuses on developing peptide-based therapeutics aimed at treating peripheral pain conditions.
Proxi Biotech develops a bacteria-resistant vaccine to treat multi-drug-resistant bacterial infections.
NanoGuard Crop is a biotechnology company focused on developing next-generation, eco-friendly biopesticides for sustainable crop protection.
Xterna is an engineering biology firm producing molecular binders that can identify certain cell types for medication delivery solutions.
Droplet IV here to create better patient outcomes and reduce the burden of nurses by building the futur of IV infusion therapy.
DARERL offers virtual human models for device development, providing digital anatomy based on real human bodies.
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat antimicrobial resistance.
Microminer is focused on developing innovative and sustainable technologies for extracting and recycling critical metals,
Beech Biotech is utilizing cutting-edge biology to develop innovative therapies for preeclampsia and other pregnancy-related issues.
METSYSTEM has a unique technology that can predict cancer metastasis and determine the best chemotherapy to treat it preventively.
3Sonic is a Med-Tech startup company that has developed a novel 3D imaging device to improve precision in cancer surgery
Cerelixis developing precision crop protection products that optimize plant growth & improve resilience to adverse environmental conditions.
FÆRM is a food technology company.
NorFalk is a biotech company that produces bio-based, sustainable surfactants for applications in consumer everyday products.
BioInnovation Institute Venture Lab has invested in 53 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioInnovation Institute Venture Lab's top investment sectors include Biotechnology, Medical, Health Care, Medical Device, Therapeutics. The firm invests across 22 different industry categories.
Among tracked funding rounds, Fuse Vectors received $5.2M in a Pre-Seed round. BioInnovation Institute Venture Lab's total known invested capital is $47.3M.
BioInnovation Institute Venture Lab's average investment size is $1.0M across its portfolio of 53 companies.
Recent BioInnovation Institute Venture Lab portfolio additions include DiaSense, SynuCa Therapeutics, Amplify Therapeutics, Aida Oncology, Incipiam Pharma. These companies were founded in 2020 or later.